Psychiatry & Neurology Doctors in Medford, NY Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Valsamma T Kandathil, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1727 N Ocean Ave, Medford, NY 11763 Phone: 631-654-1919

Luz Kelly, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 31 Industrial Boulevard, Medford, NY 11863 Phone: 631-924-4411

Dr. Richard Jay Pitch, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1739 N Ocean Ave Ste A, Medford, NY 11763 Phone: 631-714-4100    Fax: 631-714-4191

Jae Kang, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1727 N Ocean Ave, Medford, NY 11763 Phone: 631-654-1919

Dr. Jaedu Lee, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1727 N Ocean Ave, Medford, NY 11763 Phone: 631-654-1919

News Archive

Simple sight test and glasses could make a dramatic difference to the lives of more than 150 million people

Children fail at school, adults are unable to work and families are pushed into poverty as a result of uncorrected visual impairment.

PharmApprove, NDA Group partner to help life science companies navigate complex global environment

Two leading drug development and regulatory consultancies announced today that they have formed a new strategic alliance to help life science companies navigate an increasingly complex global environment.

MR Solutions wins prestigious Queen's Award for Enterprise

MR Solutions has received the prestigious Queen's Award for Enterprise from the Lord Lieutenant of Surrey at their Guildford headquarters in July to mark their achievement for innovation.

Pluristem granted two key cell therapy patents in Japan

Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing...

Celladon presents data on Phase 2 CUPID clinical trial for advanced heart failure at American Heart Association

Targeted Genetics Corporation announced that its partner, Celladon Corporation, today presented 12-month data from its Phase 2 CUPID clinical trial of MYDICAR demonstrating significant improvements in clinical outcomes and key disease markers in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.

Read more Medical News

› Verified 1 days ago